The Analgesic Efficacy of Δ9-THC (Namisol®) in Patients With Persistent Postsurgical Abdominal Pain
Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
Persistent postsurgical abdominal pain (PPAP) is a very difficult to treat pain. This pain
can persist for months or even years and significantly diminishes quality of life. The exact
underlying cause for this pain persistence is still unclear, which makes its treatment still
a challenge. The promising analgesic effects of Δ9-THC in previous research, plus the
improved bioavailability of Namisol® in comparison with previous Δ9-THC substances form the
basis of the present research proposal.
The current study aims to investigate the analgesic efficacy of Namisol® as add-on analgesic
during a long-term treatment (52 days) of persistent postsurgical abdominal pain.